![]() |
Open for inclusion |
An Open Label, Phase Ia/Ib Trial of the DNA-PK Inhibitor MSC2490484A in Combination with Radiotherapy in Patients with Advanced Solid TumorsCancer type: Solide tumores Phase: I Principal Investigator: Mau-Sørensen Morten Country: DK Keywords: Denmark, Rigshospitalet, DNA-PKI, radiotherapy Status: Open for inclusion |